Page 63 - Read Online

Persico et al. Rare Dis Orphan Drugs J 2023;2:xx https://dx.doi.org/10.20517/rdodj.2023.08 Page 19 of 21

7. Soorya L, Kolevzon A, Zweifach J, et al. Prospective investigation of autism and genotype-phenotype correlations in 22q13 deletion
syndrome and SHANK3 deficiency. Mol Autism 2013;4:18. DOI PubMed PMC
8. Sarasua SM, Boccuto L, Sharp JL, et al. Clinical and genomic evaluation of 201 patients with Phelan-McDermid syndrome. Hum
Genet 2014;133:847-59. DOI
9. Kohlenberg TM, Trelles MP, McLarney B, Betancur C, Thurm A, Kolevzon A. Psychiatric illness and regression in individuals with
Phelan-McDermid syndrome. J Neurodev Disord 2020;12:7. DOI PubMed PMC
10. Kolevzon A, Delaby E, Berry-Kravis E, Buxbaum JD, Betancur C. Neuropsychiatric decompensation in adolescents and adults with
Phelan-McDermid syndrome: a systematic review of the literature. Mol Autism 2019;10:50. DOI PubMed PMC
11. De Rubeis S, Siper PM, Durkin A, et al. Delineation of the genetic and clinical spectrum of Phelan-McDermid syndrome caused by
SHANK3 point mutations. Mol Autism 2018;9:31. DOI PubMed PMC
12. Disciglio V, Lo Rizzo C, Mencarelli MA, et al. Interstitial 22q13 deletions not involving SHANK3 gene: a new contiguous gene
syndrome. Am J Med Genet A 2014;164A:1666-76. DOI PubMed
13. Ricciardello A, Tomaiuolo P, Persico AM. Genotype-phenotype correlation in Phelan-McDermid syndrome: A comprehensive review
of chromosome 22q13 deleted genes. Am J Med Genet A 2021;185:2211-33. DOI PubMed PMC
14. Vondráčková A, Veselá K, Kratochvílová H, et al. Large copy number variations in combination with point mutations in the TYMP
and SCO2 genes found in two patients with mitochondrial disorders. Eur J Hum Genet 2014;22:431-4. DOI PubMed PMC
15. Frye RE. Mitochondrial disease in 22q13 duplication syndrome. J Child Neurol 2012;27:942-9. DOI PubMed
16. Costales JL, Kolevzon A. Phelan-McDermid sndrome and SHANK3: iplications for teatment. Neurotherapeutics 2015;12:620-30.
DOI PubMed PMC
17. Verhoeven WMA, Egger JIM, de Leeuw N. A longitudinal perspective on the pharmacotherapy of 24 adult patients with Phelan-
McDermid syndrome. Eur J Med Genet 2020;63:103751. DOI
18. Wang Y, Hekimi S. Understanding ubiquinone. Trends Cell Biol 2016;26:367-78. DOI PubMed
19. Mantle D, Dybring A. Bioavailability of cenzyme Q(10): an overview of the absorption process and subsequent metabolism.
Antioxidants 2020;9:386. DOI PubMed PMC
20. Weber C, Bysted A, Hłlmer G. The coenzyme Q10 content of the average Danish diet. Int J Vitam Nutr Res 1997;67:123-9. DOI
PubMed
21. Hargreaves IP. Coenzyme Q10 as a therapy for mitochondrial disease. Int J Biochem Cell Biol 2014;49:105e111. DOI PubMed
22. Matthews RT, Yang L, Browne S, Baik M, Beal MF. Coenzyme Q10 administration increases brain mitochondrial concentrations and
exerts neuroprotective effects. Proc Natl Acad Sci USA 1998;95:8892-7. DOI PubMed PMC
23. Rötig A, Appelkvist EL, Geromel V, et al. Quinone-responsive multiple respiratory-chain dysfunction due to widespread coenzyme
Q10 deficiency. Lancet 2000;356:391-5. DOI
24. Beal MF. Mitochondrial dysfunction and oxidative damage in Alzheimer's and Parkinson's diseases and coenzyme Q10 as a potential
treatment. J Bioenerg Biomembr 2004;36:381-6. DOI PubMed
25. Papucci L, Schiavone N, Witort E, et al. Coenzyme q10 prevents apoptosis by inhibiting mitochondrial depolarization independently
of its free radical scavenging property. J Biol Chem 2003;278:28220-8. DOI
26. Kalayci M, Unal MM, Gul S, et al. Effect of coenzyme Q10 on ischemia and neuronal damage in an experimental traumatic brain-
injury model in rats. BMC Neuroscience 2011;12:75. DOI PubMed PMC
27. Kumari S, Mehta SL, Milledge GZ, Huang X, Li H, Li PA. Ubisol-Q10 prevents glutamate-induced cell death by blocking
mitochondrial fragmentation and permeability transition pore opening. Int J Biol Sci 2016; 12:688-700. DOI PubMed PMC
28. Degenhardt F, Niklowitz P, Szymczak S, et al. Genome-wide association study of serum coenzyme Q10 levels identifies susceptibility
loci linked to neuronal diseases. Hum Mol Genet 2016;25:2881-91. DOI
29. Somayajulu M, McCarthy S, Hung M, Sikorska M, Borowy-Borowski H, Pandey S. Role of mitochondria in neuronal cell death
induced by oxidative stress; neuroprotection by Coenzyme Q10. Neurobiol Dis 2005;18:618-27. DOI PubMed
30. Moon Y, Lee KH, Park JH, Geum D, Kim K. Mitochondrial membrane depolarization and the selective death of dopaminergic neurons
by rotenone: protective effect of coenzyme Q10. J Neurochem 2005;93:1199-208. DOI
31. Hochberg J, Fortes da Silva FB. Latissimus dorsi myocutaneous flap to restore elbow flexion and axillary burn contracture: a report on
two pediatric patients. J Pediatr Orthop 1982;2:565-8. DOI PubMed
32. Müller T, Büttner T, Gholipour AF, Kuhn W. Coenzyme Q10 supplementation provides mild symptomatic benefit in patients with
Parkinson's disease. Neurosci Lett 2003;341:201-4. DOI PubMed
33. Shults CW, Beal MF, Fontaine D, Nakano K, Haas RH. Absorption, tolerability, and effects on mitochondrial activity of oral
coenzyme Q10 in parkinsonian patients. Neurology 1998;50:793-5. DOI PubMed
34. Cooper O, Seo H, Andrabi S, et al. Pharmacological rescue of mitochondrial deficits in iPSC-derived neural cells from patients with
familial Parkinson's disease. Sci Transl Med 2012;4:141ra90. DOI PubMed PMC
35. Cucinotta F, Ricciardello A, Turriziani L, et al. Efficacy and safety of Q10 ubiquinol with vitamins b and e in neurodevelopmental
disorders: a retrospective chart review. Front Psychiatry 2022;13:829516. DOI PubMed PMC
36. Psychiatric Association. Diagnostic and statistical manual of mental disorders. Med Health Care Phil 2014;17:241-244. DOI PubMed
37. Soorya L, Leon J, Trelles MP, Thurm A. Framework for assessing individuals with rare genetic disorders associated with profound
intellectual and multiple disabilities (PIMD): the example of Phelan McDermid Syndrome. Clin Neuropsychol 2018;32:1226-55. DOI
PubMed PMC